BioGaia AB’s Nomination Committee for the 2024 Annual General Meeting

BioGaia AB’s Nomination Committee for the Annual General Meeting 2024 has been appointed based on the ownership structure as of June 30, 2023.

The Nomination Committee consists of:

Peter Rothschild, Chair of the Board BioGaia AB

Per-Erik Andersson, Annwall & Rothschild Investments AB

Jacob Sellman, EQT

Marianne Flink, AP4

Russell Champion, Premier Miton Investors

Shareholders who would like to submit proposals to the Nomination Committee can do so by e-mail to [email protected] or by ordinary mail under the address BioGaia AB, Nomination Committee, Kungsbroplan 3A, 112 27 Stockholm.

The Annual General Meeting in BioGaia AB will be held on April 26, 2024, in Stockholm.

Follow us:
Subscribe to BioGaia press releases here
LinkedIn here

Peter Rothschild, Chairman of the Board
Email: [email protected]
Phone: +46 708 30 65 40

Caroline Mofors, Chief Legal Officer
Email: [email protected]
Phone: +46 733 60 48 59

About BioGaia
BioGaia is an innovative Swedish healthcare company that develops, markets, and sells probiotic products with documented health benefits. The products are sold through local distribution partners or via own distribution in over 100 markets. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm.